We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

193 hedge funds and large institutions have $3.92B invested in Dyne Therapeutics in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 79 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

527% more call options, than puts

Call options by funds: $6.11M | Put options by funds: $973K

124% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 21

72% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 46

45% more capital invested

Capital invested by funds: $2.71B → $3.92B (+$1.21B)

40% more funds holding in top 10

Funds holding in top 10: 10 → 14 (+4)

14% more funds holding

Funds holding: 169 → 193 (+24)

3.01% less ownership

Funds ownership: 116.41% → 113.4% (-3%)

Holders
193
Holders Change
+24
Holders Change %
+14.2%
% of All Funds
2.79%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.2%
New
47
Increased
79
Reduced
46
Closed
21
Calls
$6.11M
Puts
$973K
Net Calls
+$5.13M
Net Calls Change
+$11.2M

Top Buyers

1
RI
RTW Investments
New York
+$95.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$61M
3
Holocene Advisors
Holocene Advisors
New York
+$60.3M
4
BlackRock
BlackRock
New York
+$58M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$56.6M

Top Sellers

1
MAM
MPM Asset Management
Massachusetts
-$54.9M
2
LGM
Logos Global Management
California
-$42.6M
3
State Street
State Street
Massachusetts
-$28.8M
4
DTC
Deep Track Capital
Connecticut
-$16.1M
5
NCM
Nantahala Capital Management
Connecticut
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
51
VOYA Investment Management
Georgia
$9.19M +$5.33M +183,433 +238%
Invesco
52
Invesco
Georgia
$9.17M +$285K +9,814 +4%
AllianceBernstein
53
AllianceBernstein
Tennessee
$9.01M +$2.53M +87,014 +52%
Prudential Financial
54
Prudential Financial
New Jersey
$8.93M +$3.13M +107,885 +74%
UBS Group
55
UBS Group
Switzerland
$8.61M +$308K +10,602 +5%
RCM
56
Ratan Capital Management
Florida
$8.15M +$5.87M +201,900 +696%
Wellington Management Group
57
Wellington Management Group
Massachusetts
$7.99M -$258K -8,866 -4%
VPC
58
Vestal Point Capital
New York
$7.94M +$6.54M +225,000 New
Jane Street
59
Jane Street
New York
$7.6M +$3.72M +127,948 +146%
ACP
60
Acuta Capital Partners
California
$7.5M +$814K +28,000 +15%
Axa
61
Axa
France
$7.42M -$1.99M -68,417 -25%
SCM
62
Soleus Capital Management
Connecticut
$7.09M +$5.84M +201,000 New
ACM
63
Atika Capital Management
New York
$6.41M +$189K +6,500 +4%
Bank of America
64
Bank of America
North Carolina
$6.24M +$702K +24,142 +16%
Dimensional Fund Advisors
65
Dimensional Fund Advisors
Texas
$6.04M -$4.52M -155,444 -48%
Two Sigma Investments
66
Two Sigma Investments
New York
$5.62M +$4.37M +150,242 +1,686%
TD Asset Management
67
TD Asset Management
Ontario, Canada
$5.37M +$2.25M +77,410 +103%
Rafferty Asset Management
68
Rafferty Asset Management
New York
$5.13M -$5.78M -199,013 -58%
Schroder Investment Management Group
69
Schroder Investment Management Group
United Kingdom
$5.02M +$132K +4,552 +3%
UBS AM
70
UBS AM
Illinois
$4.5M +$2.8M +96,269 +308%
EGI
71
EAM Global Investors
California
$4.49M +$3.7M +127,247 New
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.46M +$1.8M +61,902 +96%
Renaissance Technologies
73
Renaissance Technologies
New York
$4.45M +$3.66M +126,000 New
Two Sigma Advisers
74
Two Sigma Advisers
New York
$4.38M +$3.21M +110,400 +812%
RhumbLine Advisers
75
RhumbLine Advisers
Massachusetts
$4.29M +$676K +23,266 +24%
1 2
3
4 5

DYN Hedge Fund Activity: Q2 2024 in Review

193 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2024, worth a combined $3.92B — up 45% from $2.71B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new DYN positions and 21 closed out — a net gain of 26 holders — while 79 added to existing stakes and 46 trimmed.

The largest buyer was RTW Investments, adding an estimated $95.8M. The largest seller was MPM Asset Management, cutting an estimated $54.9M.

  • 193 institutional investors held Dyne Therapeutics (DYN) as of Q2 2024, up from 169 in Q1 2024.
  • Funds reported $3.92B of Dyne Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
  • 47 funds opened new Dyne Therapeutics positions in Q2 2024 and 21 closed out, a net change of +26 holders.
  • The largest Dyne Therapeutics buyer in Q2 2024 was RTW Investments, an estimated $95.8M added.
  • The largest Dyne Therapeutics seller in Q2 2024 was MPM Asset Management, an estimated $54.9M sold.

Based on aggregated 13F filings for Q2 2024.